Literature DB >> 6971722

The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.

I E Tareyeva, E M Shilov, N B Gordovskaya.   

Abstract

The effects of long-term treatment with azathioprine and prednisolone on T- and B-lymphocytes were studied in 52 patients with lupus nephritis (LN) and chronic glomerulonephritis (GN). The effect of azathioprine on lymphocyte populations was dose dependent; high doses decreased the number of T- and particularly, B-cells, while smaller doses produced a selective depletion of B-cells. The changes in T- and B-cells during prednisolone treatment were variable with alternating increases and decreases in their numbers. The patients with increased B-lymphocyte levels showed the best response to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6971722

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Lymphocyte function in patients with chronic glomerulonephritis. Tests of suppressive activity generation by concanavalin A and antibody-dependent cellular cytotoxicity.

Authors:  Z Szewczyk; M Klinger; W Kopec; J Penar; E Kruźel
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

Review 2.  Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology.

Authors:  Jasper C A Broen; Jacob M van Laar
Journal:  Nat Rev Rheumatol       Date:  2020-02-13       Impact factor: 20.543

3.  Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence.

Authors:  Craig Miller; Jordan Powers; Esther Musselman; Ryan Mackie; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2019-08-30       Impact factor: 5.048

Review 4.  B cells in autoimmune hepatitis: bystanders or central players?

Authors:  Christoph Schultheiß; Silja Steinmann; Ansgar W Lohse; Mascha Binder
Journal:  Semin Immunopathol       Date:  2022-04-29       Impact factor: 11.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.